Talk to us

Life-science investment platform · sponsored by Agile Dynamics

Fund life science from a treasury built to last

AgileBio Tech pairs a rules-based Bitcoin and Treasury-bill certificate, issued in two series, with hands-on venture building. Half of every distribution above the floor buys science-pool units the holders own, with no fixed dividend.

US$50M
First close across the Growth and Core series
0.75–2.5%
Quarterly distribution floor and cap, no fixed dividend
5:1
Third-party dollars beside every science-pool dollar
Q2 2027
Target first close, 30 June 2027, after three gates

Ways to invest

Choose how you take part

Four routes into the platform, from the treasury fund to co-investing in single assets. Pick one to filter the marketplace.

Marketplace

Investment opportunities

Download each opportunity sheet as a PDF from its card. Sample companies are illustrative archetypes from our strategy, not live deals.

Tickets, timelines and returns marked as placeholders or illustrative are examples, not forecasts. Photos are illustrative.

Operating model

How money moves from treasury to science

One vehicle, two pools with different jobs, and a venture builder that does the hands-on work.

Step 1

Subscribe

Professional investors buy Growth or Core certificate units through licensed distributors.

Step 2

Apply the rule

Growth holds 57.1% Bitcoin, Core 20%, the rest in T-bills. Rebalance in up quarters; never sell Bitcoin in a down quarter.

Step 3

Distribute and route

Pay 0.75–2.5% of NAV each quarter. Half of anything above the floor buys science units the holders own.

Step 4

Fund science

The Investment Committee approves tranches of US$0.5–2.5M at 5:1; the Scientific Advisory Board verifies milestones.

Value flows back

Revenue shares capped at 2.0× from companies that already sell. Returns go to unit holders, never into the treasury.

Investors share the cycle

The link routes only upside above the floor, never capital, and holders can opt out to cash.

Venture builder

Agile Dynamics runs regulatory, business development, launch and finance services for every portfolio company.

Deal intelligence for the science pool

Which asset, which country, which deal, and what it’s really worth

OpportunityIQ is the AI business-intelligence platform Agile Dynamics is building for the AgileBio Tech ecosystem. It turns evidence from health authorities, regulators, trial registries, patent offices and licensed market data into a ranked pipeline of opportunities, each with the same auditable business case.

  • 01Sizes the demand. Patient-flow funnels from total to obtainable market, year by year.
  • 02Values each deal. Owner receipts, rNPV, IRR and peak funding for every route to market.
  • 03Gates every call. Expert sign-off before an opportunity reaches the Investment Committee.
Explore OpportunityIQ ↗Platform in development
A gloved scientist adds a drop to a test tube, surrounded by AI and molecule icons

Structure and jurisdictions

Swiss certificate. Guernsey issuer. Hong Kong sponsor.

Each job sits in the jurisdiction built for it: a Swiss-law certificate, an independent Guernsey issuer, and a Hong Kong sponsor seat that reaches professional investors through licensed intermediaries.

Summary only; terms are indicative and subject to counsel’s opinions in three jurisdictions.

Glass office towers above Victoria Harbour, Hong Kong
Switzerland

Swiss-law actively managed certificate with a CH ISIN; FINMA-supervised manager and custodian; settled through SIX SIS.

Guernsey

Incorporated cells with GFSC consent, an independent board majority and orphan ownership.

Hong Kong

Sponsor seat; professional investors reached only through licensed intermediaries.

Screening

Five sanctions lists checked at every step, with a ring-fence on both pools.

Outside mainland China

No offer, marketing, accounts or custody on the mainland, in line with PBOC Notice No. 42.

Roadmap

Raise from January to June 2027

If a gate’s conditions are not met, the date moves and the conditions do not.

Now – 15 Jan 2027

Legal setup

Counsel’s opinions in Switzerland, Guernsey and Hong Kong; Latin American tax advisers briefed.

Feb – Mar 2027

Providers and soft circle

Binding cost quotes, providers, a named CIO and CFO, then a soft circle of US$25M or more with two Latin American targets.

Apr – 30 Jun 2027

First close

US$50M binding across the Growth and Core series; fixed costs capped at US$0.5M a year.

After close

Science pool

First vintage of US$4–5M in Latin America: tranches of US$0.5–2.5M at 5:1, revenue shares capped at 2.0×.

Gate 0 15 Jan 2027 · counsel and tax advisers Gate 1 26 Feb 2027 · quotes, providers, CIO and CFO Gate 2 31 Mar 2027 · US$25M+ soft circle First close 30 Jun 2027 · US$50M binding

Get in touch

Start a conversation

Tell us whether you are an investor, a scientific partner or a growth company. We offer a 90-minute working session on structure, governance and the first deals.

Two researchers discussing a DNA visualization